WEBVTT
Kind: captions
Language: en

00:00:11.740 --> 00:00:16.320 

a<00:00:13.950> key<00:00:14.950> to<00:00:14.980> effective<00:00:15.760> treatment<00:00:15.940> of

00:00:16.320 --> 00:00:16.330 
a key to effective treatment of

00:00:16.330 --> 00:00:18.990 
a key to effective treatment of
cardiovascular<00:00:17.170> disease<00:00:17.740> is<00:00:18.039> understanding

00:00:18.990 --> 00:00:19.000 
cardiovascular disease is understanding

00:00:19.000 --> 00:00:21.780 
cardiovascular disease is understanding
the<00:00:19.119> body's<00:00:19.450> complex<00:00:20.110> lipoprotein<00:00:21.099> transport

00:00:21.780 --> 00:00:21.790 
the body's complex lipoprotein transport

00:00:21.790 --> 00:00:25.050 
the body's complex lipoprotein transport
system<00:00:22.270> at<00:00:22.540> the<00:00:23.169> operational<00:00:23.980> helm<00:00:24.340> are<00:00:24.669> Apple

00:00:25.050 --> 00:00:25.060 
system at the operational helm are Apple

00:00:25.060 --> 00:00:27.420 
system at the operational helm are Apple
lipoproteins<00:00:25.869> which<00:00:26.200> through<00:00:26.860> their<00:00:27.070> various

00:00:27.420 --> 00:00:27.430 
lipoproteins which through their various

00:00:27.430 --> 00:00:30.240 
lipoproteins which through their various
functions<00:00:28.060> such<00:00:28.599> as<00:00:28.630> enzyme<00:00:29.230> activation<00:00:29.769> and

00:00:30.240 --> 00:00:30.250 
functions such as enzyme activation and

00:00:30.250 --> 00:00:32.339 
functions such as enzyme activation and
receptor<00:00:30.760> binding<00:00:31.210> choreograph<00:00:32.169> the

00:00:32.339 --> 00:00:32.349 
receptor binding choreograph the

00:00:32.349 --> 00:00:34.259 
receptor binding choreograph the
transport<00:00:32.980> of<00:00:33.070> lipids<00:00:33.489> from<00:00:33.760> sites<00:00:34.059> of

00:00:34.259 --> 00:00:34.269 
transport of lipids from sites of

00:00:34.269 --> 00:00:36.750 
transport of lipids from sites of
absorption<00:00:34.960> or<00:00:35.110> synthesis<00:00:35.769> to<00:00:36.220> sites<00:00:36.519> of

00:00:36.750 --> 00:00:36.760 
absorption or synthesis to sites of

00:00:36.760 --> 00:00:39.720 
absorption or synthesis to sites of
utilization<00:00:37.739> this<00:00:38.739> system<00:00:39.250> cycles

00:00:39.720 --> 00:00:39.730 
utilization this system cycles

00:00:39.730 --> 00:00:42.360 
utilization this system cycles
triglycerides<00:00:40.600> for<00:00:41.019> distribution<00:00:41.379> to<00:00:41.920> muscle

00:00:42.360 --> 00:00:42.370 
triglycerides for distribution to muscle

00:00:42.370 --> 00:00:45.210 
triglycerides for distribution to muscle
for<00:00:42.640> energy<00:00:43.120> use<00:00:43.360> or<00:00:43.750> to<00:00:44.049> adipose<00:00:44.500> tissue<00:00:44.830> for

00:00:45.210 --> 00:00:45.220 
for energy use or to adipose tissue for

00:00:45.220 --> 00:00:47.939 
for energy use or to adipose tissue for
storage<00:00:45.729> and<00:00:46.000> it<00:00:46.299> cycles<00:00:46.780> cholesterol<00:00:47.500> for

00:00:47.939 --> 00:00:47.949 
storage and it cycles cholesterol for

00:00:47.949 --> 00:00:50.189 
storage and it cycles cholesterol for
distribution<00:00:48.820> throughout<00:00:49.150> the<00:00:49.449> body<00:00:49.659> for

00:00:50.189 --> 00:00:50.199 
distribution throughout the body for

00:00:50.199 --> 00:00:52.859 
distribution throughout the body for
cell<00:00:50.440> membrane<00:00:50.979> bile<00:00:51.489> acid<00:00:52.059> and<00:00:52.239> steroid

00:00:52.859 --> 00:00:52.869 
cell membrane bile acid and steroid

00:00:52.869 --> 00:00:55.829 
cell membrane bile acid and steroid
hormone<00:00:53.320> synthesis<00:00:53.979> a<00:00:54.390> complimentary<00:00:55.390> cycle

00:00:55.829 --> 00:00:55.839 
hormone synthesis a complimentary cycle

00:00:55.839 --> 00:00:57.979 
hormone synthesis a complimentary cycle
called<00:00:56.260> reverse<00:00:56.830> cholesterol<00:00:57.129> transport

00:00:57.979 --> 00:00:57.989 
called reverse cholesterol transport

00:00:57.989 --> 00:01:02.009 
called reverse cholesterol transport
completes<00:00:58.989> the<00:00:59.290> system<00:01:00.360> Applebee<00:01:01.360> containing

00:01:02.009 --> 00:01:02.019 
completes the system Applebee containing

00:01:02.019 --> 00:01:04.979 
completes the system Applebee containing
lipoproteins<00:01:02.860> also<00:01:03.519> called<00:01:03.790> non<00:01:04.089> HDL

00:01:04.979 --> 00:01:04.989 
lipoproteins also called non HDL

00:01:04.989 --> 00:01:07.910 
lipoproteins also called non HDL
comprised<00:01:05.770> the<00:01:05.979> lipid<00:01:06.369> delivery<00:01:06.820> pathway

00:01:07.910 --> 00:01:07.920 
comprised the lipid delivery pathway

00:01:07.920 --> 00:01:11.280 
comprised the lipid delivery pathway
while<00:01:08.920> Apple<00:01:09.369> a1<00:01:09.850> containing<00:01:10.479> lipoproteins

00:01:11.280 --> 00:01:11.290 
while Apple a1 containing lipoproteins

00:01:11.290 --> 00:01:14.010 
while Apple a1 containing lipoproteins
or<00:01:11.530> HDL<00:01:12.450> participate<00:01:13.450> in<00:01:13.630> reverse

00:01:14.010 --> 00:01:14.020 
or HDL participate in reverse

00:01:14.020 --> 00:01:16.590 
or HDL participate in reverse
cholesterol<00:01:14.290> transport<00:01:15.600> Applebee

00:01:16.590 --> 00:01:16.600 
cholesterol transport Applebee

00:01:16.600 --> 00:01:18.959 
cholesterol transport Applebee
containing<00:01:17.200> lipoproteins<00:01:18.009> originate<00:01:18.759> from

00:01:18.959 --> 00:01:18.969 
containing lipoproteins originate from

00:01:18.969 --> 00:01:22.319 
containing lipoproteins originate from
two<00:01:19.270> sources<00:01:19.539> an<00:01:20.100> intestinal<00:01:21.159> Applebee<00:01:21.759> 48

00:01:22.319 --> 00:01:22.329 
two sources an intestinal Applebee 48

00:01:22.329 --> 00:01:25.709 
two sources an intestinal Applebee 48
lineage<00:01:22.810> and<00:01:23.109> a<00:01:23.859> hepatic<00:01:24.219> Applebee<00:01:25.060> 100

00:01:25.709 --> 00:01:25.719 
lineage and a hepatic Applebee 100

00:01:25.719 --> 00:01:29.910 
lineage and a hepatic Applebee 100
lineage<00:01:27.539> traveling<00:01:28.539> along<00:01:28.840> similar<00:01:29.350> pathways

00:01:29.910 --> 00:01:29.920 
lineage traveling along similar pathways

00:01:29.920 --> 00:01:32.910 
lineage traveling along similar pathways
Applebee<00:01:30.909> particles<00:01:31.479> are<00:01:31.749> remodeled<00:01:32.530> into

00:01:32.910 --> 00:01:32.920 
Applebee particles are remodeled into

00:01:32.920 --> 00:01:35.399 
Applebee particles are remodeled into
smaller<00:01:33.280> and<00:01:33.640> smaller<00:01:34.140> cholesterol<00:01:35.140> rich

00:01:35.399 --> 00:01:35.409 
smaller and smaller cholesterol rich

00:01:35.409 --> 00:01:37.889 
smaller and smaller cholesterol rich
remnants<00:01:36.070> as<00:01:36.189> triglycerides<00:01:36.729> are<00:01:37.509> released

00:01:37.889 --> 00:01:37.899 
remnants as triglycerides are released

00:01:37.899 --> 00:01:40.469 
remnants as triglycerides are released
in<00:01:38.140> the<00:01:38.229> form<00:01:38.499> of<00:01:38.710> fatty<00:01:38.979> acids<00:01:39.579> to<00:01:39.789> peripheral

00:01:40.469 --> 00:01:40.479 
in the form of fatty acids to peripheral

00:01:40.479 --> 00:01:43.440 
in the form of fatty acids to peripheral
tissue<00:01:41.130> let's<00:01:42.130> take<00:01:42.429> a<00:01:42.460> closer<00:01:42.819> look<00:01:42.999> at<00:01:43.299> this

00:01:43.440 --> 00:01:43.450 
tissue let's take a closer look at this

00:01:43.450 --> 00:01:46.109 
tissue let's take a closer look at this
process<00:01:43.719> the<00:01:44.619> newly<00:01:45.009> assembled<00:01:45.310> Applebee

00:01:46.109 --> 00:01:46.119 
process the newly assembled Applebee

00:01:46.119 --> 00:01:48.300 
process the newly assembled Applebee
containing<00:01:46.689> lipoproteins<00:01:47.469> are<00:01:47.740> secreted

00:01:48.300 --> 00:01:48.310 
containing lipoproteins are secreted

00:01:48.310 --> 00:01:50.669 
containing lipoproteins are secreted
from<00:01:48.460> the<00:01:48.549> intestine<00:01:49.270> or<00:01:49.479> liver<00:01:49.899> into<00:01:50.560> the

00:01:50.669 --> 00:01:50.679 
from the intestine or liver into the

00:01:50.679 --> 00:01:53.910 
from the intestine or liver into the
lymph<00:01:50.950> or<00:01:51.219> plasma<00:01:51.880> respectively<00:01:52.920> secreted

00:01:53.910 --> 00:01:53.920 
lymph or plasma respectively secreted

00:01:53.920 --> 00:01:57.270 
lymph or plasma respectively secreted
with<00:01:54.130> them<00:01:54.369> are<00:01:54.689> apolipoproteins<00:01:55.689> ii<00:01:55.979> c2<00:01:56.979> and

00:01:57.270 --> 00:01:57.280 
with them are apolipoproteins ii c2 and

00:01:57.280 --> 00:01:58.260 
with them are apolipoproteins ii c2 and
c3

00:01:58.260 --> 00:01:58.270 
c3

00:01:58.270 --> 00:02:00.870 
c3
these<00:01:59.100> apolipoproteins<00:02:00.100> may<00:02:00.310> also<00:02:00.549> be

00:02:00.870 --> 00:02:00.880 
these apolipoproteins may also be

00:02:00.880 --> 00:02:04.410 
these apolipoproteins may also be
acquired<00:02:01.270> from<00:02:01.569> HDL<00:02:02.639> with<00:02:03.639> attachment<00:02:04.299> to

00:02:04.410 --> 00:02:04.420 
acquired from HDL with attachment to

00:02:04.420 --> 00:02:07.050 
acquired from HDL with attachment to
proteoglycans<00:02:05.350> on<00:02:05.560> capillary<00:02:06.159> endothelium

00:02:07.050 --> 00:02:07.060 
proteoglycans on capillary endothelium

00:02:07.060 --> 00:02:09.150 
proteoglycans on capillary endothelium
the<00:02:07.600> lipoprotein<00:02:07.920> remodeling<00:02:08.920> process

00:02:09.150 --> 00:02:09.160 
the lipoprotein remodeling process

00:02:09.160 --> 00:02:13.290 
the lipoprotein remodeling process
begins<00:02:10.200> here<00:02:11.230> Apple<00:02:11.920> c2<00:02:12.490> activates

00:02:13.290 --> 00:02:13.300 
begins here Apple c2 activates

00:02:13.300 --> 00:02:15.270 
begins here Apple c2 activates
lipoprotein<00:02:14.230> lipase

00:02:15.270 --> 00:02:15.280 
lipoprotein lipase

00:02:15.280 --> 00:02:18.059 
lipoprotein lipase
PL<00:02:15.760> which<00:02:16.360> hydrolyzes<00:02:17.170> the<00:02:17.200> lipoproteins

00:02:18.059 --> 00:02:18.069 
PL which hydrolyzes the lipoproteins

00:02:18.069 --> 00:02:20.820 
PL which hydrolyzes the lipoproteins
core<00:02:18.430> triglycerides<00:02:19.240> into<00:02:19.569> free<00:02:19.959> fatty<00:02:20.260> acids

00:02:20.820 --> 00:02:20.830 
core triglycerides into free fatty acids

00:02:20.830 --> 00:02:23.280 
core triglycerides into free fatty acids
which<00:02:21.370> diffused<00:02:21.940> through<00:02:22.270> the<00:02:22.420> capillary<00:02:22.990> to

00:02:23.280 --> 00:02:23.290 
which diffused through the capillary to

00:02:23.290 --> 00:02:27.420 
which diffused through the capillary to
muscle<00:02:23.709> or<00:02:23.890> adipose<00:02:24.490> cells<00:02:25.530> as<00:02:26.530> fatty<00:02:26.920> acids

00:02:27.420 --> 00:02:27.430 
muscle or adipose cells as fatty acids

00:02:27.430 --> 00:02:30.059 
muscle or adipose cells as fatty acids
exit<00:02:27.910> the<00:02:28.209> lipoproteins<00:02:28.959> become<00:02:29.350> smaller<00:02:29.770> and

00:02:30.059 --> 00:02:30.069 
exit the lipoproteins become smaller and

00:02:30.069 --> 00:02:33.330 
exit the lipoproteins become smaller and
smaller<00:02:30.180> remnants<00:02:31.180> in<00:02:31.830> remodeling<00:02:32.830> of<00:02:33.310> the

00:02:33.330 --> 00:02:33.340 
smaller remnants in remodeling of the

00:02:33.340 --> 00:02:36.420 
smaller remnants in remodeling of the
Appleby<00:02:34.030> 100<00:02:34.690> lineage<00:02:35.080> a<00:02:35.350> further<00:02:35.800> step<00:02:36.190> by

00:02:36.420 --> 00:02:36.430 
Appleby 100 lineage a further step by

00:02:36.430 --> 00:02:40.680 
Appleby 100 lineage a further step by
hepatic<00:02:36.970> lipase<00:02:37.510> HL<00:02:38.580> transforms<00:02:39.580> remnant<00:02:40.120> IDL

00:02:40.680 --> 00:02:40.690 
hepatic lipase HL transforms remnant IDL

00:02:40.690 --> 00:02:44.040 
hepatic lipase HL transforms remnant IDL
particles<00:02:41.319> to<00:02:41.739> LDL<00:02:42.630> during<00:02:43.630> the<00:02:43.780> modeling

00:02:44.040 --> 00:02:44.050 
particles to LDL during the modeling

00:02:44.050 --> 00:02:47.340 
particles to LDL during the modeling
remnants<00:02:44.890> of<00:02:45.010> both<00:02:45.160> Appleby<00:02:45.850> 48<00:02:46.450> and<00:02:46.720> Appleby

00:02:47.340 --> 00:02:47.350 
remnants of both Appleby 48 and Appleby

00:02:47.350 --> 00:02:51.390 
remnants of both Appleby 48 and Appleby
100<00:02:47.980> pathways<00:02:48.489> shed<00:02:49.350> apolipoproteins<00:02:50.350> II<00:02:50.709> c2

00:02:51.390 --> 00:02:51.400 
100 pathways shed apolipoproteins II c2

00:02:51.400 --> 00:02:57.320 
100 pathways shed apolipoproteins II c2
and<00:02:51.700> c3<00:02:52.090> which<00:02:52.959> then<00:02:53.230> reassociate<00:02:53.890> with<00:02:54.489> HDL

00:02:57.320 --> 00:02:57.330 

00:02:57.330 --> 00:02:59.940 

eventually<00:02:58.330> most<00:02:58.570> Appleby<00:02:59.290> remnants<00:02:59.800> are

00:02:59.940 --> 00:02:59.950 
eventually most Appleby remnants are

00:02:59.950 --> 00:03:02.040 
eventually most Appleby remnants are
recycled<00:03:00.550> to<00:03:00.610> the<00:03:00.790> liver<00:03:01.030> through<00:03:01.450> the<00:03:01.540> LDL

00:03:02.040 --> 00:03:02.050 
recycled to the liver through the LDL

00:03:02.050 --> 00:03:06.180 
recycled to the liver through the LDL
receptor<00:03:02.319> related<00:03:03.100> protein<00:03:03.610> l<00:03:03.880> RP<00:03:04.450> or<00:03:05.190> LDL

00:03:06.180 --> 00:03:06.190 
receptor related protein l RP or LDL

00:03:06.190 --> 00:03:10.530 
receptor related protein l RP or LDL
receptors<00:03:07.950> however<00:03:08.950> Apple<00:03:09.250> be<00:03:09.730> remnants<00:03:10.000> can

00:03:10.530 --> 00:03:10.540 
receptors however Apple be remnants can

00:03:10.540 --> 00:03:13.470 
receptors however Apple be remnants can
have<00:03:10.810> other<00:03:11.110> metabolic<00:03:11.590> fates<00:03:12.220> for<00:03:12.910> example

00:03:13.470 --> 00:03:13.480 
have other metabolic fates for example

00:03:13.480 --> 00:03:16.350 
have other metabolic fates for example
LDL<00:03:14.260> may<00:03:14.560> be<00:03:14.620> taken<00:03:15.100> up<00:03:15.250> by<00:03:15.280> peripheral<00:03:15.940> cells

00:03:16.350 --> 00:03:16.360 
LDL may be taken up by peripheral cells

00:03:16.360 --> 00:03:19.140 
LDL may be taken up by peripheral cells
for<00:03:16.720> its<00:03:16.810> cholesterol<00:03:17.440> content<00:03:17.800> or<00:03:18.340> of<00:03:18.880> more

00:03:19.140 --> 00:03:19.150 
for its cholesterol content or of more

00:03:19.150 --> 00:03:21.660 
for its cholesterol content or of more
clinical<00:03:19.720> concern<00:03:20.400> chylomicron<00:03:21.400> remnants

00:03:21.660 --> 00:03:21.670 
clinical concern chylomicron remnants

00:03:21.670 --> 00:03:25.199 
clinical concern chylomicron remnants
and<00:03:22.150> LDL<00:03:22.660> may<00:03:23.350> become<00:03:23.739> targets<00:03:24.100> for<00:03:24.370> uptake<00:03:24.910> by

00:03:25.199 --> 00:03:25.209 
and LDL may become targets for uptake by

00:03:25.209 --> 00:03:30.630 
and LDL may become targets for uptake by
the<00:03:25.269> arterial<00:03:25.989> wall<00:03:26.230> macrophage<00:03:29.640> excess

00:03:30.630 --> 00:03:30.640 
the arterial wall macrophage excess

00:03:30.640 --> 00:03:33.150 
the arterial wall macrophage excess
Applebee<00:03:31.360> containing<00:03:31.989> particles<00:03:32.500> can<00:03:32.829> invade

00:03:33.150 --> 00:03:33.160 
Applebee containing particles can invade

00:03:33.160 --> 00:03:37.319 
Applebee containing particles can invade
the<00:03:33.400> arterial<00:03:34.000> wall<00:03:34.440> become<00:03:35.440> oxidized<00:03:36.190> and<00:03:36.519> be

00:03:37.319 --> 00:03:37.329 
the arterial wall become oxidized and be

00:03:37.329 --> 00:03:39.479 
the arterial wall become oxidized and be
taken<00:03:37.570> up<00:03:37.840> by<00:03:37.870> macrophage<00:03:38.709> scavenger

00:03:39.479 --> 00:03:39.489 
taken up by macrophage scavenger

00:03:39.489 --> 00:03:42.060 
taken up by macrophage scavenger
receptors<00:03:40.060> creating<00:03:40.989> the<00:03:41.110> foam<00:03:41.350> cells<00:03:41.739> that

00:03:42.060 --> 00:03:42.070 
receptors creating the foam cells that

00:03:42.070 --> 00:03:45.900 
receptors creating the foam cells that
lead<00:03:42.340> to<00:03:42.640> atheroma<00:03:43.859> now<00:03:44.859> let's<00:03:45.160> examine<00:03:45.370> the

00:03:45.900 --> 00:03:45.910 
lead to atheroma now let's examine the

00:03:45.910 --> 00:03:49.500 
lead to atheroma now let's examine the
complementary<00:03:46.750> a<00:03:46.780> po<00:03:47.200> a<00:03:47.230> 1<00:03:47.739> or<00:03:48.040> HDL<00:03:48.970> pathway

00:03:49.500 --> 00:03:49.510 
complementary a po a 1 or HDL pathway

00:03:49.510 --> 00:03:53.229 
complementary a po a 1 or HDL pathway
that<00:03:49.900> protects<00:03:50.470> from<00:03:50.530> a<00:03:50.799> thorough<00:03:51.010> Genesis

00:03:53.229 --> 00:03:53.239 
that protects from a thorough Genesis

00:03:53.239 --> 00:03:56.240 
that protects from a thorough Genesis
HDLs<00:03:54.269> to<00:03:54.510> major<00:03:54.930> a<00:03:55.110> thorough<00:03:55.530> protective

00:03:56.240 --> 00:03:56.250 
HDLs to major a thorough protective

00:03:56.250 --> 00:03:58.309 
HDLs to major a thorough protective
roles<00:03:56.519> are<00:03:56.849> reversed<00:03:57.049> cholesterol<00:03:58.049> transport

00:03:58.309 --> 00:03:58.319 
roles are reversed cholesterol transport

00:03:58.319 --> 00:04:01.130 
roles are reversed cholesterol transport
and<00:03:58.950> properties<00:03:59.730> which<00:04:00.000> prevent<00:04:00.540> LDL

00:04:01.130 --> 00:04:01.140 
and properties which prevent LDL

00:04:01.140 --> 00:04:03.740 
and properties which prevent LDL
oxidation<00:04:02.099> a<00:04:02.280> key<00:04:02.730> trigger<00:04:03.060> for<00:04:03.420> a<00:04:03.450> thorough

00:04:03.740 --> 00:04:03.750 
oxidation a key trigger for a thorough

00:04:03.750 --> 00:04:05.309 
oxidation a key trigger for a thorough
Genesis

00:04:05.309 --> 00:04:05.319 
Genesis

00:04:05.319 --> 00:04:07.380 
Genesis
let's<00:04:06.250> look<00:04:06.549> at<00:04:06.700> reverse<00:04:07.120> cholesterol

00:04:07.380 --> 00:04:07.390 
let's look at reverse cholesterol

00:04:07.390 --> 00:04:10.920 
let's look at reverse cholesterol
transport<00:04:08.189> to<00:04:09.189> begin<00:04:09.579> horley<00:04:10.269> lipid<00:04:10.599> ated

00:04:10.920 --> 00:04:10.930 
transport to begin horley lipid ated

00:04:10.930 --> 00:04:13.679 
transport to begin horley lipid ated
Apple<00:04:11.319> a1<00:04:11.799> is<00:04:12.069> secreted<00:04:12.730> from<00:04:12.969> the<00:04:13.120> liver<00:04:13.359> and

00:04:13.679 --> 00:04:13.689 
Apple a1 is secreted from the liver and

00:04:13.689 --> 00:04:16.409 
Apple a1 is secreted from the liver and
intestine<00:04:14.469> and<00:04:14.650> released<00:04:15.370> into<00:04:15.730> the<00:04:15.849> plasma

00:04:16.409 --> 00:04:16.419 
intestine and released into the plasma

00:04:16.419 --> 00:04:18.569 
intestine and released into the plasma
for<00:04:16.690> circulation<00:04:17.259> to<00:04:17.650> peripheral<00:04:18.280> cells

00:04:18.569 --> 00:04:18.579 
for circulation to peripheral cells

00:04:18.579 --> 00:04:20.900 
for circulation to peripheral cells
where<00:04:19.299> it<00:04:19.449> removes<00:04:19.870> excess<00:04:20.199> cholesterol

00:04:20.900 --> 00:04:20.910 
where it removes excess cholesterol

00:04:20.910 --> 00:04:25.469 
where it removes excess cholesterol
forming<00:04:21.910> nascent<00:04:22.389> HDL<00:04:23.050> HDL<00:04:24.330> removal<00:04:25.330> of

00:04:25.469 --> 00:04:25.479 
forming nascent HDL HDL removal of

00:04:25.479 --> 00:04:27.570 
forming nascent HDL HDL removal of
cholesterol<00:04:26.169> from<00:04:26.410> cells<00:04:26.740> is<00:04:27.039> of<00:04:27.310> utmost

00:04:27.570 --> 00:04:27.580 
cholesterol from cells is of utmost

00:04:27.580 --> 00:04:29.610 
cholesterol from cells is of utmost
importance<00:04:28.479> when<00:04:28.780> those<00:04:28.990> cells<00:04:29.289> are

00:04:29.610 --> 00:04:29.620 
importance when those cells are

00:04:29.620 --> 00:04:31.650 
importance when those cells are
cholesterol<00:04:30.009> Laden<00:04:30.699> arterial<00:04:31.419> wall

00:04:31.650 --> 00:04:31.660 
cholesterol Laden arterial wall

00:04:31.660 --> 00:04:33.740 
cholesterol Laden arterial wall
macrophages

00:04:33.740 --> 00:04:33.750 
macrophages

00:04:33.750 --> 00:04:36.860 
macrophages
let's<00:04:34.750> examine<00:04:34.990> several<00:04:35.860> of<00:04:35.979> HDL<00:04:36.520> cholesterol

00:04:36.860 --> 00:04:36.870 
let's examine several of HDL cholesterol

00:04:36.870 --> 00:04:40.980 
let's examine several of HDL cholesterol
removing<00:04:37.870> mechanisms<00:04:39.750> excess<00:04:40.750> cholesterol

00:04:40.980 --> 00:04:40.990 
removing mechanisms excess cholesterol

00:04:40.990 --> 00:04:44.189 
removing mechanisms excess cholesterol
in<00:04:41.710> the<00:04:41.800> macrophage<00:04:42.430> triggers<00:04:43.150> up<00:04:43.419> regulation

00:04:44.189 --> 00:04:44.199 
in the macrophage triggers up regulation

00:04:44.199 --> 00:04:47.820 
in the macrophage triggers up regulation
of<00:04:44.380> the<00:04:44.500> abca1<00:04:45.509> transporter<00:04:46.509> and<00:04:46.660> a<00:04:47.169> hydrolase

00:04:47.820 --> 00:04:47.830 
of the abca1 transporter and a hydrolase

00:04:47.830 --> 00:04:50.400 
of the abca1 transporter and a hydrolase
which<00:04:48.280> converts<00:04:48.729> cholesterol<00:04:49.539> ester<00:04:50.050> in<00:04:50.259> the

00:04:50.400 --> 00:04:50.410 
which converts cholesterol ester in the

00:04:50.410 --> 00:04:55.189 
which converts cholesterol ester in the
lipid<00:04:50.650> pool<00:04:51.009> to<00:04:51.490> free<00:04:51.759> cholesterol<00:04:53.070> the<00:04:54.070> abca1

00:04:55.189 --> 00:04:55.199 
lipid pool to free cholesterol the abca1

00:04:55.199 --> 00:04:57.839 
lipid pool to free cholesterol the abca1
transporter<00:04:56.199> operates<00:04:56.860> to<00:04:57.130> harvest<00:04:57.610> this

00:04:57.839 --> 00:04:57.849 
transporter operates to harvest this

00:04:57.849 --> 00:04:59.909 
transporter operates to harvest this
free<00:04:58.120> cholesterol<00:04:58.509> and<00:04:59.080> deliver<00:04:59.590> it<00:04:59.740> to<00:04:59.770> the

00:04:59.909 --> 00:04:59.919 
free cholesterol and deliver it to the

00:04:59.919 --> 00:05:02.310 
free cholesterol and deliver it to the
cell<00:05:00.250> membrane<00:05:00.330> where<00:05:01.330> it<00:05:01.449> is<00:05:01.570> acquired<00:05:01.960> by

00:05:02.310 --> 00:05:02.320 
cell membrane where it is acquired by

00:05:02.320 --> 00:05:05.460 
cell membrane where it is acquired by
poorly<00:05:02.680> lipid<00:05:03.160> ated<00:05:03.490> Apple<00:05:04.000> a1<00:05:04.539> to<00:05:05.080> create

00:05:05.460 --> 00:05:05.470 
poorly lipid ated Apple a1 to create

00:05:05.470 --> 00:05:09.570 
poorly lipid ated Apple a1 to create
nascent<00:05:06.160> HDL<00:05:07.380> the<00:05:08.380> transporter<00:05:09.190> shuttles

00:05:09.570 --> 00:05:09.580 
nascent HDL the transporter shuttles

00:05:09.580 --> 00:05:12.060 
nascent HDL the transporter shuttles
back<00:05:09.849> and<00:05:10.120> forth<00:05:10.389> transferring<00:05:11.380> cholesterol

00:05:12.060 --> 00:05:12.070 
back and forth transferring cholesterol

00:05:12.070 --> 00:05:16.469 
back and forth transferring cholesterol
from<00:05:12.400> the<00:05:12.460> macrophage<00:05:13.180> to<00:05:13.599> HDL<00:05:14.909> next<00:05:15.909> the<00:05:16.240> free

00:05:16.469 --> 00:05:16.479 
from the macrophage to HDL next the free

00:05:16.479 --> 00:05:19.560 
from the macrophage to HDL next the free
cholesterol<00:05:16.720> on<00:05:17.500> HDL<00:05:18.099> surface<00:05:18.699> is<00:05:18.849> esterified

00:05:19.560 --> 00:05:19.570 
cholesterol on HDL surface is esterified

00:05:19.570 --> 00:05:22.680 
cholesterol on HDL surface is esterified
by<00:05:20.110> lecithin<00:05:20.800> cholesterol<00:05:21.490> acyl<00:05:22.000> transferase

00:05:22.680 --> 00:05:22.690 
by lecithin cholesterol acyl transferase

00:05:22.690 --> 00:05:26.250 
by lecithin cholesterol acyl transferase
or<00:05:22.960> L<00:05:23.560> cap<00:05:23.949> the<00:05:24.669> cholesterol<00:05:25.360> ester<00:05:25.900> then

00:05:26.250 --> 00:05:26.260 
or L cap the cholesterol ester then

00:05:26.260 --> 00:05:28.950 
or L cap the cholesterol ester then
moves<00:05:26.560> to<00:05:26.740> the<00:05:26.949> lipoproteins<00:05:27.699> core<00:05:28.120> forming

00:05:28.950 --> 00:05:28.960 
moves to the lipoproteins core forming

00:05:28.960 --> 00:05:32.089 
moves to the lipoproteins core forming
the<00:05:29.139> more<00:05:29.289> spherical<00:05:29.740> mature<00:05:30.550> HDL<00:05:31.449> three

00:05:32.089 --> 00:05:32.099 
the more spherical mature HDL three

00:05:32.099 --> 00:05:35.760 
the more spherical mature HDL three
further<00:05:33.099> cholesterol<00:05:33.970> removal<00:05:34.570> by<00:05:34.780> HDL<00:05:35.380> 3

00:05:35.760 --> 00:05:35.770 
further cholesterol removal by HDL 3

00:05:35.770 --> 00:05:38.730 
further cholesterol removal by HDL 3
occurs<00:05:36.310> through<00:05:36.729> SRB<00:05:37.599> one<00:05:37.870> receptors<00:05:38.500> in

00:05:38.730 --> 00:05:38.740 
occurs through SRB one receptors in

00:05:38.740 --> 00:05:42.450 
occurs through SRB one receptors in
membrane<00:05:39.280> cholesterol<00:05:40.000> pools<00:05:40.300> as<00:05:41.099> HDL<00:05:42.099> three

00:05:42.450 --> 00:05:42.460 
membrane cholesterol pools as HDL three

00:05:42.460 --> 00:05:44.909 
membrane cholesterol pools as HDL three
collects<00:05:43.000> more<00:05:43.270> cholesterol<00:05:43.659> and<00:05:44.260> is<00:05:44.500> acted

00:05:44.909 --> 00:05:44.919 
collects more cholesterol and is acted

00:05:44.919 --> 00:05:49.410 
collects more cholesterol and is acted
on<00:05:45.039> by<00:05:45.310> L<00:05:45.520> cat<00:05:45.820> it<00:05:46.090> expands<00:05:46.930> to<00:05:46.990> HDL<00:05:47.800> 2

00:05:49.410 --> 00:05:49.420 
on by L cat it expands to HDL 2

00:05:49.420 --> 00:05:54.270 
on by L cat it expands to HDL 2
as<00:05:49.590> we've<00:05:50.590> seen<00:05:50.950> abca1<00:05:51.940> and<00:05:52.720> SRB<00:05:53.410> one<00:05:53.650> are<00:05:53.890> key

00:05:54.270 --> 00:05:54.280 
as we've seen abca1 and SRB one are key

00:05:54.280 --> 00:06:02.940 
as we've seen abca1 and SRB one are key
devices<00:05:54.670> for<00:05:55.210> cholesterol<00:05:55.540> efflux

00:06:02.940 --> 00:06:02.950 

00:06:02.950 --> 00:06:06.480 

however<00:06:03.930> HDL<00:06:04.930> also<00:06:05.440> collects<00:06:05.890> cholesterol

00:06:06.480 --> 00:06:06.490 
however HDL also collects cholesterol

00:06:06.490 --> 00:06:09.270 
however HDL also collects cholesterol
from<00:06:06.760> both<00:06:06.910> lipid<00:06:07.390> rafts<00:06:07.630> and<00:06:07.900> caviola<00:06:08.380> within

00:06:09.270 --> 00:06:09.280 
from both lipid rafts and caviola within

00:06:09.280 --> 00:06:12.540 
from both lipid rafts and caviola within
the<00:06:09.430> cell<00:06:09.670> membrane<00:06:10.180> in<00:06:10.930> these<00:06:11.260> ways<00:06:11.590> HDL

00:06:12.540 --> 00:06:12.550 
the cell membrane in these ways HDL

00:06:12.550 --> 00:06:14.970 
the cell membrane in these ways HDL
facilitates<00:06:13.360> cholesterol<00:06:14.080> a<00:06:14.290> flux<00:06:14.620> from<00:06:14.890> the

00:06:14.970 --> 00:06:14.980 
facilitates cholesterol a flux from the

00:06:14.980 --> 00:06:18.060 
facilitates cholesterol a flux from the
macrophage<00:06:16.080> now<00:06:17.080> rich<00:06:17.500> in<00:06:17.710> cholesterol

00:06:18.060 --> 00:06:18.070 
macrophage now rich in cholesterol

00:06:18.070 --> 00:06:22.380 
macrophage now rich in cholesterol
esters<00:06:19.000> HDL<00:06:19.990> 2<00:06:20.290> engages<00:06:21.130> in<00:06:21.310> an<00:06:21.460> exchange<00:06:21.760> with

00:06:22.380 --> 00:06:22.390 
esters HDL 2 engages in an exchange with

00:06:22.390 --> 00:06:25.470 
esters HDL 2 engages in an exchange with
triglyceride<00:06:23.140> rich<00:06:23.440> lipoproteins<00:06:24.480> mediated

00:06:25.470 --> 00:06:25.480 
triglyceride rich lipoproteins mediated

00:06:25.480 --> 00:06:28.230 
triglyceride rich lipoproteins mediated
by<00:06:25.630> cholesterol<00:06:26.350> ester<00:06:26.740> transfer<00:06:27.250> protein<00:06:27.760> C

00:06:28.230 --> 00:06:28.240 
by cholesterol ester transfer protein C

00:06:28.240 --> 00:06:29.840 
by cholesterol ester transfer protein C
ETP

00:06:29.840 --> 00:06:29.850 
ETP

00:06:29.850 --> 00:06:32.640 
ETP
cholesterol<00:06:30.850> ester<00:06:31.270> from<00:06:31.480> HDL<00:06:32.050> 2<00:06:32.380> is

00:06:32.640 --> 00:06:32.650 
cholesterol ester from HDL 2 is

00:06:32.650 --> 00:06:34.860 
cholesterol ester from HDL 2 is
transferred<00:06:33.430> to<00:06:33.640> Apple<00:06:34.060> B<00:06:34.270> containing

00:06:34.860 --> 00:06:34.870 
transferred to Apple B containing

00:06:34.870 --> 00:06:37.260 
transferred to Apple B containing
lipoproteins<00:06:35.650> in<00:06:35.920> a<00:06:36.130> one<00:06:36.370> to<00:06:36.550> one<00:06:36.580> exchange

00:06:37.260 --> 00:06:37.270 
lipoproteins in a one to one exchange

00:06:37.270 --> 00:06:40.620 
lipoproteins in a one to one exchange
for<00:06:37.570> triglycerides<00:06:38.460> the<00:06:39.460> result<00:06:39.880> further

00:06:40.620 --> 00:06:40.630 
for triglycerides the result further

00:06:40.630 --> 00:06:42.750 
for triglycerides the result further
cholesterol<00:06:41.470> enrichment<00:06:42.070> of<00:06:42.160> Apple<00:06:42.580> B

00:06:42.750 --> 00:06:42.760 
cholesterol enrichment of Apple B

00:06:42.760 --> 00:06:45.300 
cholesterol enrichment of Apple B
lipoproteins<00:06:43.600> and<00:06:43.870> triglyceride<00:06:44.710> enrichment

00:06:45.300 --> 00:06:45.310 
lipoproteins and triglyceride enrichment

00:06:45.310 --> 00:06:49.380 
lipoproteins and triglyceride enrichment
of<00:06:45.460> HDL<00:06:46.180> HDL<00:06:47.250> may<00:06:48.250> now<00:06:48.430> have<00:06:48.730> one<00:06:49.000> of<00:06:49.120> three

00:06:49.380 --> 00:06:49.390 
of HDL HDL may now have one of three

00:06:49.390 --> 00:06:52.110 
of HDL HDL may now have one of three
faiths<00:06:49.720> h<00:06:50.260> dales<00:06:50.740> triglycerides<00:06:51.610> may<00:06:52.060> be

00:06:52.110 --> 00:06:52.120 
faiths h dales triglycerides may be

00:06:52.120 --> 00:06:54.900 
faiths h dales triglycerides may be
hydrolyzed<00:06:52.840> by<00:06:53.020> hepatic<00:06:53.650> lipase<00:06:54.100> converting

00:06:54.900 --> 00:06:54.910 
hydrolyzed by hepatic lipase converting

00:06:54.910 --> 00:07:00.750 
hydrolyzed by hepatic lipase converting
it<00:06:55.060> back<00:06:55.090> to<00:06:55.540> HDL<00:06:56.080> 3<00:06:57.420> or<00:06:58.500> HDL<00:06:59.500> 2<00:06:59.830> can<00:07:00.160> return<00:07:00.520> to

00:07:00.750 --> 00:07:00.760 
it back to HDL 3 or HDL 2 can return to

00:07:00.760 --> 00:07:02.850 
it back to HDL 3 or HDL 2 can return to
the<00:07:00.880> liver<00:07:01.140> interacting<00:07:02.140> with<00:07:02.320> scavenger

00:07:02.850 --> 00:07:02.860 
the liver interacting with scavenger

00:07:02.860 --> 00:07:05.880 
the liver interacting with scavenger
receptor<00:07:03.370> SR<00:07:03.790> b1<00:07:04.240> which<00:07:04.690> removes<00:07:05.140> cholesterol

00:07:05.880 --> 00:07:05.890 
receptor SR b1 which removes cholesterol

00:07:05.890 --> 00:07:09.840 
receptor SR b1 which removes cholesterol
converting<00:07:06.790> it<00:07:06.910> back<00:07:07.120> to<00:07:07.420> HDL<00:07:07.960> 3<00:07:08.350> or<00:07:08.850> finally

00:07:09.840 --> 00:07:09.850 
converting it back to HDL 3 or finally

00:07:09.850 --> 00:07:14.040 
converting it back to HDL 3 or finally
HDL<00:07:10.660> two<00:07:10.960> may<00:07:11.290> be<00:07:11.320> catabolized<00:07:12.130> by<00:07:12.580> the<00:07:12.640> liver

00:07:14.040 --> 00:07:14.050 
HDL two may be catabolized by the liver

00:07:14.050 --> 00:07:16.770 
HDL two may be catabolized by the liver
as<00:07:14.169> we<00:07:14.860> have<00:07:15.069> seen<00:07:15.370> these<00:07:15.909> complementary

00:07:16.770 --> 00:07:16.780 
as we have seen these complementary

00:07:16.780 --> 00:07:19.230 
as we have seen these complementary
systems<00:07:17.259> work<00:07:17.590> in<00:07:17.830> elegant<00:07:18.430> harmony<00:07:18.970> to

00:07:19.230 --> 00:07:19.240 
systems work in elegant harmony to

00:07:19.240 --> 00:07:21.600 
systems work in elegant harmony to
choreograph<00:07:19.629> the<00:07:20.139> body's<00:07:20.530> lipid<00:07:20.979> needs<00:07:21.250> and

00:07:21.600 --> 00:07:21.610 
choreograph the body's lipid needs and

00:07:21.610 --> 00:07:24.119 
choreograph the body's lipid needs and
as<00:07:22.120> science<00:07:22.539> continues<00:07:22.990> to<00:07:23.229> unravel<00:07:23.560> these

00:07:24.119 --> 00:07:24.129 
as science continues to unravel these

00:07:24.129 --> 00:07:26.040 
as science continues to unravel these
intricacies<00:07:24.879> of<00:07:24.909> normal<00:07:25.569> lipid<00:07:25.900> metabolism

00:07:26.040 --> 00:07:26.050 
intricacies of normal lipid metabolism

00:07:26.050 --> 00:07:29.969 
intricacies of normal lipid metabolism
our<00:07:27.039> ability<00:07:27.849> to<00:07:28.090> understand<00:07:28.780> diagnose<00:07:29.710> and

00:07:29.969 --> 00:07:29.979 
our ability to understand diagnose and

00:07:29.979 --> 00:07:32.219 
our ability to understand diagnose and
manage<00:07:30.460> various<00:07:31.150> dis<00:07:31.479> lipedema<00:07:31.960> --is

00:07:32.219 --> 00:07:32.229 
manage various dis lipedema --is

00:07:32.229 --> 00:07:35.699 
manage various dis lipedema --is
continues<00:07:33.069> to<00:07:33.310> improve

